Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Huji Xu
CONTACT
Lead
China Immunotech (Beijing) Biotechnology Co., Ltd.
With
This study is a prospective exploratory clinical trial in subjects with recurrent/refractory autoimmune disease. The objective is to evaluate the safety, initial efficacy and PK/PD characteristics of YTS109 cells in the treatment of recurrent/refractory autoimmune diseases.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted